Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Last Hour:
Last 24 Hours:

Global Cancer/Tumor Profiling Market 2016 Share, Trend, Segmentation and Forecast to 2022

Sunday, October 9, 2016 22:18
% of readers think this story is Fact. Add your two cents.

(Before It's News)

According to researcher, the Global Cancer/Tumor Profiling market is expected to grow from $23.04 billion in 2015 to reach $78.69 billion by 2022 with a CAGR of 19.2%. Increasing cases of cancer and the need for therapy are the major factors influencing the market growth. Moreover, high investments in R&D, technological developments, and demand for safer medicines are the factors fostering the market growth. However, low awareness among clinicians about options and potential of cancer profiling are the major challenges for this market.

By application, personalized medicines segment leads the market globally with the biggest market share and is expected to grow with a high CAGR during the forecast period. The growth is attributed by unique characteristics of this segment in examining and prognosis of cancer disease. North America commands the market due to the presence of leading cancer profiling industry leaders. Asia Pacific is expected to witness huge growth due to raising incidence of cancer in this region.

Request a sample report @

Some of the key players in global Cancer/Tumor profiling market include Agendia Nv, Biotheranostics, Boreal Genomics, Inc., Caris Life Sciences, Genomic Health, Inc., Illumina, Inc., Life Technologies Corporation, Nanostring Technologies, Neogenomics Laboratories, Oncopath Laboratory, Oxford Gene Technology Ltd, Precision Therapeutics, Inc., Proteome Sciences Plc, Rational Therapeutics, and Ribomed Biotechnologies.

Applications Covered: 
• Biomarker Discovery 
• Diagnostics 
• Personalized Medicine 
• Prognosis 
• Research Applications

Technologies Covered: 
• Fluorescence/Chromogenic In Situ Hybridization 
• Immunohistochemistry 
• Microarray 
• Next-Generation Sequencing 
• Quantitative PCR

Get this report @

What our report offers: 
- Market share assessments for the regional and country level segments 
- Market share analysis of the top industry players 
- Strategic recommendations for the new entrants 
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets 
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) 
- Strategic recommendations in key business segments based on the market estimations 
- Competitive landscaping mapping the key common trends 
- Company profiling with detailed strategies, financials, and recent developments 
- Supply chain trends mapping the latest technological advancements

Key points in table of content

1 Executive Summary 

2 Preface 
2.1 Abstract 
2.2 Stake Holders 
2.3 Research Scope 
2.4 Research Methodology 
2.4.1 Data Mining 
2.4.2 Data Analysis 
2.4.3 Data Validation 
2.4.4 Research Approach 
2.5 Research Sources 
2.5.1 Primary Research Sources 
2.5.2 Secondary Research Sources 
2.5.3 Assumptions 

3 Market Trend Analysis 
3.1 Introduction 
3.2 Drivers 
3.3 Restraints 
3.4 Opportunities 
3.5 Threats 
3.6 Application Analysis 
3.7 Technology Analysis 
3.8 Emerging Markets 

4 Porters Five Force Analysis 
4.1 Bargaining power of suppliers 
4.2 Bargaining power of buyers 
4.3 Threat of substitutes 
4.4 Threat of new entrants 
4.5 Competitive rivalry 

5 Global Cancer/Tumor Profiling Market, By Application 
5.1 Introduction 
5.2 Biomarker Discovery 
5.3 Diagnostics 
5.4 Personalized Medicine 
5.5 Prognosis 
5.6 Research Applications 

6 Global Cancer/Tumor Profiling Market, By Technology 
6.1 Introduction 
6.2 Fluorescence/Chromogenic In Situ Hybridization 
6.3 Immunohistochemistry 
6.4 Microarray 
6.5 Next-Generation Sequencing 
6.6 Quantitative PCR 

7 Global Cancer/Tumor Profiling Market, By Geography 
7.1 North America 
7.1.1 US 
7.1.2 Canada 
7.1.3 Mexico 
7.2 Europe 
7.2.1 Germany 
7.2.2 France 
7.2.3 Italy 
7.2.4 UK 
7.2.5 Spain 
7.2.6 Rest of Europe 
7.3 Asia Pacific 
7.3.1 Japan 
7.3.2 China 
7.3.3 India 
7.3.4 Australia 
7.3.5 New Zealand 
7.3.6 Rest of Asia Pacific 
7.4 Rest of the World 
7.4.1 Middle East 
7.4.2 Brazil 
7.4.3 Argentina 
7.4.4 South Africa 
7.4.5 Egypt 

8 Key Developments 
8.1 Agreements, Partnerships, Collaborations and Joint Ventures 
8.2 Acquisitions & Mergers 
8.3 New Product Launch 
8.4 Expansions 
8.5 Other Key Strategies 

9 Company Profiling 
9.1 Agendia Nv 
9.2 Biotheranostics 
9.3 Boreal Genomics, Inc. 
9.4 Caris Life Sciences 
9.5 Genomic Health, Inc. 
9.6 Illumina, Inc. 
9.7 Life Technologies Corporation 
9.8 Nanostring Technologies 
9.9 Neogenomics Laboratories 
9.10 Oncopath Laboratory 
9.11 Oxford Gene Technology Ltd 
9.12 Precision Therapeutics, Inc. 
9.13 Proteome Sciences Plc 
9.14 Rational Therapeutics 
9.15 Ribomed Biotechnologies 

Complete report details @         

Contact US:


Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.